Mostrando 3 resultados de: 3
Subtipo de publicación
Other(3)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(2)
Medicina y salud(2)
Problemas sociales y servicios a grupos(2)
Origen
scopus(3)
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
OtherAbstract: Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particuPalabras claves:covid-19, Multiple Sclerosis, ocrelizumab, pandemic, rituximabAutores:Carcamo Rodriguez C., Carmisciano L., Ciampi E., Edgar Patricio Correa, Fragoso Y.D., Gomes S., Pimentel M.L.V., Ponzano M., Santos G.A.C., Schiavetti I., Sormani M.P., Steinberg J., Treviño-Frenk I., Vecino M.C.A., Vrech C., Winckler T.C.A.Fuentes:scopusPractical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
OtherAbstract: Abstract: The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin AmePalabras claves:Alemtuzumab, Biological drugs, Biosimilar, Glatiramoids, Interferon beta, Multiple Sclerosis, Natalizumab, ocrelizumabAutores:Carcamo Rodriguez C., Carra A., Ciampi E., Duran Quiroz J.C., Edgar Patricio Correa, Fragoso Y.D., García J.R., Guerra C., Macias M.A., Novarro N., Oehninger Gatti C., Orozco G., Rodriguez V., Steinberg J., Vizcarra D.Fuentes:scopusPractical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group
OtherAbstract: MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis hPalabras claves:clinical research, Latin America, MRI, Multiple SclerosisAutores:Carcamo Rodriguez C., Carra A., Ciampi E., Cortes-Enriquez F., Edgar Patricio Correa, Fragoso Y.D., Garcia Bónitto J., Guerra-Posada C., Macias M.A., Novarro N., Steinberg J., Treviño-Frenk I., Vizcarra D., Vrech C.Fuentes:scopus